Skip to content

Climb Bio, Inc. CLYM Change in Other Assets

Change in Other Assets at other companies

Amgen logo
AmgenAMGN
-$8M-104%
Vera Therapeutics logo
Vera TherapeuticsVERA
$5.14M-12.5%
Kyverna Therapeutics, Inc. logo
Kyverna Therapeutics, Inc.KYTX
$5K-99.0%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$662K+138%
Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO
$1.86M+765%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
-$1.08M-48.8%

Other financials

Income statement

See full
Operating income-$15.2M+33.9%
Net income-$13.7M+34.0%
EPS (diluted)-$0.20+35.5%

Balance sheet

See full
Cash & equivalents$8.4M-71.2%
Total debt$479.0K+1.1%
Total equity$148.1M-23.4%
Total assets$152.4M-24.1%

Cash flow

See full
Operating cash flow-$14.4M+6.8%
CapEx$109.0K
Free cash flow-$15.6M-183%

Valuation

See full
Market cap$724.95M+787%
Enterprise value$717.07M+1,247%

Returns & leverage

See full
Return on equity-30.9%-10.3pp
Debt / equity0.0×
Current ratio27.9×+13.6×

Where this comes from

Reported directly by Climb Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentAssets.

The official record: Climb Bio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Climb Bio, Inc.'s change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Climb Bio, Inc.'s change in other assets?
Climb Bio, Inc. (CLYM) reported change in other assets of -$0 in Q1 2026.
How has Climb Bio, Inc.'s change in other assets changed year-over-year?
Climb Bio, Inc.'s change in other assets decreased by 100.0% year-over-year, from $10K to -$0.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.